Безопасность лекарственных средств, применяемых во время беременности при тошноте (рвоте) и кислотозависимых заболеваниях


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Приводятся данные о безопасности во время беременности лекарственных средств, применяемых для лечения тошноты (рвоты) и кислотозависимых заболеваний.

Полный текст

Доступ закрыт

Об авторах

Е. Ушкалова

Научный центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова

Email: eushk@yandex.ru
доктор медицинских наук, профессор

Список литературы

  1. Saha S., Manlolo J., McGowan C. et al. Gastroenterology consultations in pregnancy // J. Womens Health (Larchmt). 2011; 20 (3): 359-63.
  2. Bianco A., Lockwood С., Barss V. Maternal gastrointestinal tract adaptation to pregnancy. Uptodate, 2012 http://www.uptodate.com/contents/maternal-gastrointestinal-tract-adaptation-to-pregnancy
  3. Seto A., Einarson T., Koren G. Pregnancy outcome following first trimester exposure to antihistamines: Meta-analysis // Am. J. Perinatol. 1997; 14: 119-24.
  4. Magee L., Mazzotta P., Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP) // Am. J. Obstet. Gynecol. 2002; 186: 256-61.
  5. Mazzotta P., Magee L. A risk-benefit assessment of pharmacological and nonpharmacological treatment of nausea and vomiting of pregnancy // Drugs. -2000; 59 (4): 781-800.
  6. King T., Murphy P. Evidence-Based Approaches to Managing Nausea and Vomiting in Early Pregnancy // J. Midwifery Womens Health. 2009; 54 (6): 430
  7. Kallen B., Mottet I. Delivery outcome after the use of meclozine in early pregnancy // Eur. J. Epidemiol. 2003; 18 (7): 665-9.
  8. Asker C., Norstedt-Wikner B., Kallen B. Use of antiemetic drugs during pregnancy in Sweden // Eur. J. Clin. Pharmacol. 2005; 61 (12): 899-906.
  9. Arsenault M., Lane C., MacKinnon C. et al. The management of nausea and vomiting of pregnancy // J. Obstet. Gynaecol. Can. 2002; 24 (10): 817-31.
  10. McKeigue P., Lamm S., Linn S. et al. Bendectin and birth defects: I. A metaanalysis of the epidemiologic studies // Teratology. 1994; 50: 27.
  11. Matthews A., Dowswell T., Haas D. et al. Interventions for nausea and vomiting in early pregnancy // Cochrane Database Syst. Rev. 2010; 9: CD007575. 82013 ВРАЧ фармакология
  12. Arsenault M., Lane C., MacKinnon C. et al. The management of nausea and vomiting of pregnancy // J. Obstet. Gynaecol. Can. 2002; 24 (10): 817-31.
  13. FDA approves Diclegis for pregnant women experiencing nausea and vomiting http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm347087.htm
  14. Ding M., Leach M., Bradley H. The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: A systematic review // Women Birth. -2013; 26 (1): 26-30.
  15. Almeida J., Riordan S. The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy // Exp. Opin. Drug. Saf. -2007; 6 (5): 493-503.
  16. Sorensen H., Nielsen G., Christensen K. et al. Birth outcome following maternal use of metoclopramide. The Euromap study group // Br. J. Clin. Pharmacol. 2000; 49: 264-68.
  17. Berkovitch M., Mazzota P., Greenberg R. et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study // Am. J. Perinatol. 2002; 19: 311-6.
  18. Asker C., Norstedt-Wikner B., Kallen B. Use of antiemetic drugs during pregnancy in Sweden // Eur. J. Clin. Pharmacol. 2005; 61: 899-906.
  19. US department of education and welfare phs, national institutes of health: The Collaborative Study of the National Institute of Neurological Diseases: the women and their pregnancies. DHEW Publication No. (NIH) 73-379 (1972).
  20. Schwethel M., Margolis L., Miller C. et al. Risk status and pregnancy outcome among Medicaid recipients // Am. J. Prev. Med. 1989; 5: 157-63.
  21. Einarson-Maltepe C., Navioz Y. et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study // BJOG. 2004; 111: 940-3.
  22. Richter J. Review article: the management of heartburn in pregnancy // Aliment. Pharmacol. Ther. 2005; 22: 749-57.
  23. Mahadevan U., Kane S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy // Gastroenterology. 2006; 131 (1): 278-82.
  24. Mahadevan U. Gastrointestinal medications in pregnancy // Best Pract. Res. Clin. Gastroenterol. 2007; 21 (5): 849-77.
  25. McGuinness Bio, Logan J. Milk alkali syndrome // Ulster Med. J. 2002; 71 (2): 132-5.
  26. Gordon M., McMahon L., Hamblin P. Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy // Med. J. Aust. 2005; 182 (7): 350-1.
  27. Harris B., Choma D. et al. Hypercalcemia in Pregnancy: A Case of Milk-Alkali Syndrome // J. Gen. Intern. Med. 2011; 26 (8): 939-42.
  28. Robertson W. Calcium carbonate consumption during pregnancy: an unusual cause of neonatal hypocalcemia // J. Child. Neurol. 2002; 17: 853-5.
  29. Charan M., Katz P. Gastroesophageal reflux disease in pregnancy // Cur. Treat. Opt. Gastroenterol. 2001; 4: 73-81.
  30. Briggs G., Freeman R., Yaffe S. Drugs in Pregnancy and Lactation. Philadelphia, Lippincott Williams & Wilkins, 2008.
  31. Cappell M. Gastric and duodenal ulcers during pregnancy // Gastroenterol. Clin. North. Am. 2003; 32: 263-308.
  32. Gill S., O'Brien L., Koren G. The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis // Dig. Dis. Sci. 2009; 54 (9): 1835-8.
  33. Matok I., Gorodischer R., Koren G. et al. The safety of H(2)-blockers use during pregnancy // J. Clin. Pharmacol. 2010; 50 (1): 81-7.
  34. Cappell M., Friedel D. Abdominal pain during pregnancy // Gastroenterol. Clin. North Am. 2003; 32 (1): 1-58.
  35. Fill S., Malfertheiner M., Costa S. et al. Handling of the gastroesophageal reflux disease (GERD) during pregnancy a review // Z. Geburtshilfe Neonatol. -2007; 211 (6): 215-23.
  36. Gill S., O'Brien L., Einarson T. et al. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis // Am. J. Gastroenterol. 2009; 104 (6): 1541-5.
  37. Majithia R., Johnson D. Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date // Drugs. 2012; 72 (2): 171-9.
  38. Erichsen R., Mikkelsen E., Pedersen L. et al. Maternal Use of Proton Pump Inhibitors During Early Pregnancy and the Prevalence of Hypospadias in Male Offspring // Am. J. Ther., 2012; Epub. ahead of print.
  39. Dulgheru R. The Safety and Efficiency of Proton Pump Inhibitors during Pregnancy and Conception // Maedica (Buchar). 2010; 5 (4): 304.
  40. Matok I., Levy A., Wiznitzer A. et al. The safety of fetal exposure to proton-pump inhibitors during pregnancy // Dig. Dis. Sci. 2012; 57 (3): 699-705.
  41. Pasternak B., Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects // N. Engl. J. Med. 2010; 363: 2114.
  42. Andersen A., Erichsen R., Farkas D. et al. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study // Aliment Pharmacol. Ther. 2012; 35 (10): 1190-8.
  43. Jonville A., Lionnet C., Swar A. et al. Drug utilization at the end of pregnancy // Therapie. 1991; 46: 379-82.
  44. Kallen B. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole // Br. J. Obstet. Gynaecol. 1998; 105: 877-81.
  45. Ruigomez A., Garcia-Rodriguez L., Cattaruzzi C. et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes // Am. J. Epidemiol. 1999; 150: 476-81.
  46. Magee L., Inocencion G., Kamboj L. et al. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study // Dig. Dis. Sci. 1996; 41: 1145-9.
  47. Garbis H., Elefant E., Diav-Citrin O. et al. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services // Reprod. Toxicol. 2005; 19: 453-8.
  48. Ruigomez A., Garcia-Rodriguez L., Cattaruzzi C. et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes // Am. J. Epidemiol. 1999; 150: 476.
  49. Diav-Citrin O., Arnon J., Shechtman S. et al. The safety of proton pump inhibitors in pregnancy: a multi-centre prospective controlled study // Aliment. Pharmacol. Ther. 2005; 21: 269-75.
  50. Kallen B. Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy // Eur. J. Obstet. Gynecol. Reprod. Biol. -2001; 96 (1): 63-8.
  51. Lalkin A., Loebstein R., Addis A. et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study // Am. J. Obstet. Gynecol. -1998; 179: 727-30.
  52. Shaban M., Kandil H., Elshafei A. Helicobacter Pylori Seropositivity in Patients With Hyperemesis Gravidarum // Am. J. Med. Sci., 2013. Epub. ahead of print.
  53. Mansour G., Nashaat E. Role of Helicobacter pylori in the pathogenesis of hyperemesis gravidarum // Arch. Gynecol. Obstet. 2011; 284 (4): 843-7.
  54. Einarson A., Phillips E., Mawji F. et al. A prospective controlled multicentre study of clarithromycin in pregnancy // Am. J. Perinatol. 1998; 15 (9): 523-5.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ИД "Русский врач", 2013

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах